Cleared Traditional

K253612 - Acclarent AERA Eustachian Tube Balloon Dilation System (FDA 510(k) Clearance)

Feb 2026
Decision
93d
Days
Class 2
Risk

K253612 is an FDA 510(k) clearance for the Acclarent AERA Eustachian Tube Balloon Dilation System. This device is classified as a Eustachian Tube Balloon Dilation Device (Class II - Special Controls, product code PNZ).

Submitted by Acclarent, Inc. (Irvine, US). The FDA issued a Cleared decision on February 19, 2026, 93 days after receiving the submission on November 18, 2025.

This device falls under the Ear, Nose, Throat FDA review panel. Regulated under 21 CFR 874.4180. The Device Is Intended For Use In Dilating The Cartilaginous Portion Of The Eustachian Tube For Treating Persistent Eustachian Tube Dysfunction..

Submission Details

510(k) Number K253612 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 2025
Decision Date February 19, 2026
Days to Decision 93 days
Submission Type Traditional
Review Panel Ear, Nose, Throat (EN)
Summary Summary PDF

Device Classification

Product Code PNZ — Eustachian Tube Balloon Dilation Device
Device Class Class II - Special Controls
CFR Regulation 21 CFR 874.4180
Definition The Device Is Intended For Use In Dilating The Cartilaginous Portion Of The Eustachian Tube For Treating Persistent Eustachian Tube Dysfunction.